InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Mulligan Seamus, Director. Officer active across 1 company, notably Jazz Pharmaceuticals plc. Cumulatively, 9 disclosures have been recorded. Split: 1 buy · 0 sell. Total volume traded: €7.1m. Activity tracked since 29 July 2021. The latest transaction was filed on 5 August 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Mulligan Seamus
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
1,605 shares0Ordinary SharesSEC:0001536639-26-000004:0
3,507 shares0Ordinary SharesSEC:0001765581-25-000076:0
80,684 shares@ US$98.104692.3% of flowOrdinary SharesSEC:0001765581-25-000042:0
Canonical exit: 7 Aug 2025 (T+90)
3,731 shares0Ordinary SharesSEC:0001765581-24-000070:0
3,075 shares0Ordinary SharesSEC:0001765581-23-000086:0
4,500 shares@ US$81.764.5% of flowOrdinary SharesSEC:0001765581-23-000052:0
4,500 shares@ US$59.133.3% of flowOrdinary SharesSEC:0001765581-23-000010:0
2,561 shares0Ordinary SharesSEC:0001765581-22-000090:0
2,246 shares0Ordinary SharesSEC:0001765581-21-000075:0
9 of 9 declarations
About Mulligan Seamus
Mulligan Seamus is Administrateur at Jazz Pharmaceuticals plc (XNAS). He has 9 filings in total, and among the sampled recent filings, the transactions show EUR 7052131 of buys and EUR 0 of sells, over a period from 2021-08-02 to 2026-08-07, with the transaction nature mainly indicated as Attribution.
